LET'S BE FRIENDS WITH RESEARCH BENEFITS
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978747
- Registration number
- 7681719
- Mark type
- Stylized text
- Filed
- 14 Dec 2022
- Published for opposition
- 24 Oct 2023
- Registered
- 04 Feb 2025
- Attorney of record
- Alexis Crawford Douglas
Goods and services
- Class 035 — Advertising and business services: Recruitment advertisement services, namely, posting of clinical trial and health research notices for the purpose of recruiting patients for participation in clinical trials and health research; Promoting public awareness of clinical trials and scientific research; Business consulting and management in the field of clinical trials and health research, namely, management and compilation of computerized databases in the field of clinical trials and health research for business purposes
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials and health research for others; Providing medical and scientific research information in the field of clinical trials; Providing an Internet website portal in the field of clinical trials and scientific research
Owner
- Institute for Translational Medicine, Chicago, IL, US
- Institute for Translational Medicine, Chicago, IL, US
- Institute for Translational Medicine, Chicago, IL, US
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Sept 2024 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 05 Sept 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 03 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Aug 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Jun 2024 — USE AMENDMENT FILED
- 20 Aug 2024 — DIVISIONAL PROCESSING COMPLETE
- 20 Jun 2024 — DIVISIONAL REQUEST RECEIVED
- 20 Jun 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Aug 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Jun 2024 — TEAS STATEMENT OF USE RECEIVED